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Abstract. Ephrin-B3 is important in the regulation of cell 
proliferation, differentiation and migration via cell-cell contact, 
and can activate the reelin pathway during brain development. 
However, the effect of ephrin-B3 on hippocampal neurogen-
esis and the reelin pathway in epilepsy remains to be fully 
elucidated. In the present study, the expression of ephrin-B3 
in pilocarpine-induced status epilepticus (SE) rats was inves-
tigated. SYBR Green-based reverse transcription-quantitative 
polymerase chain reaction analysis, immunohistochemical 
labeling and western blot analysis were used to detect the gene 
and protein expression levels of ephrin-B3 and reelin pathway 
proteins. Immunofluorescence staining of doublecortin 
(dcX) was utilized to analyze hippocampal neurogenesis. 
The data revealed that the mRNA and protein expression 
levels of ephrin-B3 in the hippocampus decreased during the 
spontaneous seizure period. Of note, the expression of reelin 
and its downstream phosphorylation disabled 1 (p-dab1) were 
also notably decreased during the spontaneous seizure period, 
which showed similar dynamic changes as in the expression 
of ephrin-B3. In addition, it was found that the number of 
dcX-labeled neuronal progenitor cells was increased in the 
hippocampus following pilocarpine-induced SE. To further 
clarify the role of ephrin-B3 in neurogenesis and the reelin 
pathway in epilepsy, an exogenous ephrin-B3 clustering stimu-
lator, EphB3-Fc, was infused into the bilateral hippocampus of 
the rats post-SE. Following EphB3-Fc injection, it was found 
that the expression levels of reelin and p‑Dab1 were signifi-
cantly increased in the epileptic rats following EphB3-Fc 
injection. The number of dcX-labeled neuronal progenitor 
cells was reduced in the hippocampus of the epileptic rats. 
Furthermore, the intensity and frequency of spontaneous 
recurrent seizures and electroencephalographic seizures were 
attenuated in the epileptic rats post-injection. These results 
demonstrated the critical role of ephrin-B3 in regulation of 
the reelin pathway and hippocampal neurogenesis in epilepsy, 
providing experimental evidence that ephrin-B3 functions as a 
potential protective factor in epilepsy, at least in animals.
Introduction
Epilepsy is one of the most prevalent chronic neurological 
disorders, which affects ~65,000,000 individuals worldwide 
and is a global burden in terms of seizure-related disability, 
comorbidities and mortality rates (1). clinically, temporal lobe 
epilepsy (TLE) is the most common form of drug-resistant and 
intractable epilepsy, and is characterized by recurrent spon-
taneous seizures (SRS) due to neuronal hyperactivity in the 
brain (2). Abnormal hippocampal neurogenesis is a prominent 
feature of TLE, which may contribute to the hippocampal 
network plasticity associated with epilepsy (3). The newborn 
neuron can be labeled by doublecortin (dcX), a marker of 
transit-amplifying cells and immature newborn neurons, 
which begin to have neuronal potential (4). These newborn 
neurons are continuously generated in the subgranular zone 
of the hippocampal dentate gyrus, migrate into the granule 
layer and terminally differentiate, mainly into new granule 
cell neurons (5). The newly generated ectopic granule cells 
have immature synapses and exhibit spontaneous discharge, 
which may be an important pathophysiological basis for 
chronic spontaneous seizures (6). However, the molecular 
mechanisms that regulate hippocampal neurogenesis during 
the spontaneous seizure period remain to be fully elucidated.
Ephrins, ligands for Eph receptors, are membrane-bound 
proteins which are the largest member of the receptor tyrosine 
kinase family and can be divided into A and B subclasses, 
binding either A-class or B-class ligands; ephrin ligands 
and receptors are important in the regulation of morpho-
logic processes, including axon guidance, angiogenesis, cell 
migration and positioning, in the central nervous system (7). 
Increasing roles of the transmembrane ephrin-B3 ligand have 
been revealed in the central nervous system. In the hippocampal 
Ephrin‑B3 modulates hippocampal neurogenesis and the reelin 
signaling pathway in a pilocarpine‑induced model of epilepsy
TIAN-TIAN LIU1,2,  YI LI3,  YI SHU4,  BO XIAO1  and  LI FENG1
1department of Neurology, Xiangya Hospital, central South University, changsha, Hunan 410008; 
2Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China; 
3department of Neurology, University of Massachusetts Medical School, Worcester, MA 01604, USA;  
4Department of Neurology, Second Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China
Received October 9, 2017;  Accepted March 5, 2018
dOI: 10.3892/ijmm.2018.3543
Correspondence to: dr Bo Xiao or dr Li Feng, department of 
Neurology, Xiangya Hospital, central South University, 87 Xiangya 
Road, Changsha, Hunan 410008, P.R. China
E-mail: xiaobo_xy@126.com
E-mail: fengli1982@yahoo.com.cn
Key words: epilepsy, ephrin-B3, reelin pathway, neurogenesis, 
neuronal excitability
LIU et al:  ROLE OF EPHRIN‑B3 IN NEUROGENESIS AND REELIN PATHWAY IN EPILEPSY3458
dentate gyrus, ephrin-B3/Eph-B1 is involved in several func-
tions, including neuronal progenitor sorting, stochastic cell 
migration and guidance of neuronal growth cones during the 
early developing brain (8). Ephrin-B3 can also reduce cell 
death by inhibiting the functions of EphA4 receptors during 
adult neurogenesis in the subventricular zone of the brain (9). 
Based on these reports, the present study hypothesized that 
ephrin-B3 may affect hippocampal neurogenesis during the 
spontaneous seizure period following pilocarpine-induced 
epilepsy.
Ephrin-B3 can function by the regulation of other signaling 
pathways via cell-cell interactions, including the regulation of 
glutamate receptor signaling by inducing the tyrosine phos-
phorylation of NR2 subunits in glutamatergic cA1 synapses 
in the hippocampus (10). Of note, ephrin-B3 is involved 
in the activation of the reelin signaling pathway, which is 
essential in controlling neuronal migration in the neocortex, 
hippocampus and cerebellum of reelin-deficient mutant 
reeler mice (11,12). Reelin is an extracellular protein, which 
affects several stages of neuronal migration and layering in 
the developing brain; reelin protein acts mainly by binding 
to low-density lipoprotein receptors and apolipoprotein E 
receptor 2, and then initiates the tyrosine phosphorylation of 
intracytoplasmic docking disabled protein 1 (dab1) (13). The 
reelin pathway control the shapes, sizes and types of dendritic 
spines, and synaptic homeostasis; its dysregulation may occur 
in neurological and psychiatric disorders, including epilepsy, 
targeting hippocampal circuits (14). Although the functions 
of ephrin-B3 and the reelin pathway during physiological 
or pathological neurodevelopment are clear, the function of 
ephrin-B3 in modulation of the reelin pathway in epilepsy 
remains to be fully elucidated.
The aim of the present study was to investigate the role 
of ephrin-B3 in hippocampal neurogenesis and the reelin 
pathway in a pilocarpine-induced rat model, and to examine 
the potential mechanism underlying the effect of ephrin-B3 on 
cell proliferation and the reelin pathway in pilocarpine-induced 
SE rats.
Materials and methods
Pilocarpine‑induced SE. The animals were provided by the 
Shanghai Laboratory Animal center (Shanghai, china) and 
housed at the Experimental Animal center of central South 
University (changsha, china) at a temperature of 23±1˚C with 
a regular 12-h light/dark cycle and free access to food and 
water. All animal experiments were performed in accordance 
with the official recommendations of the Institutional Animal 
care and Use committee of the Institute of Laboratory Animal 
Science of central South University (no. 201403142).
A total of 70 healthy, young male Sprague-dawley rats 
(aged 6-8 weeks, 200-250 g) were treated with pilocarpine 
(25 mg/kg, i.p., Sigma-Aldrich; EMd Millipore, Billerica, 
MA, USA) to induce epilepsy. The rats were administered 
with lithium chloride (127 mg/kg, i.p., Sigma-Aldrich; 
EMd Millipore) 18-22 h prior to pilocarpine injection. 
According to Racine's classification, SE was defined as 
continuous seizures lasting at least 30 min, and rats classified 
as Racine stage IV‑V that fulfilled the SE criterion were used 
in the present study (15). Following pilocarpine injection, the 
rats spent ~30 min in the SE phase in Racine stage IV or V. 
The matched controls (n=35) were injected i.p. with the same 
volume of normal saline instead of lithium chloride and 
pilocarpine, and were used as corresponding controls. All rats 
were administered with chloral hydrate injection (3 ml/kg, 
i.p.; Tonghua Pharmaceutical, Tonghua, China) to terminate 
behavioral seizures or limit behavioral seizures.
Ephrin‑B3 stimulation experiment. On day 7 following the 
onset of SE, the epileptic and control rats were anesthetized 
with 10% chloral hydrate (3 ml/kg, i.p.) and were then fixed on 
a stereotaxic apparatus (RWd Life Science, Shenzhen, china). 
The skin was shaved and sterilized with iodine complex. The 
scalp was dissected in the middle line and retracted bilater-
ally to expose the sagittal and coronal sutures. Based on 
the Rat Brain Stereotaxic Atlas (16), bilateral hippocampal 
regions were selected as sites for implantation. Two vertical 
bone holes were drilled symmetrically 1.6 mm adjacent to the 
sagittal suture and 3.6 mm posterior to the anterior fontanel, 
with the anterior fontanel as the center. A micro-osmotic 
pump (ALZET®; dUREcT corporation, cupertino, cA, 
USA) connected to a cannula (ALZET® brain infusion kit) was 
inserted 2.8 mm under the dura, and an infusion of Eph B3-Fc 
suspension (recombinant mouse EphB3-Fc chimera; 50 µg/ml; 
R&d Systems, Inc., Minneapolis, MN, USA) or Fc (50 µg/ml; 
Jackson ImmunoResearch Laboratories, Inc., West Grove, PA, 
USA) were injected into the brain for 7 days. The cannula 
was cemented onto the skull with dental acrylic. Following 
removal of the pumps from the skull, the wound was washed 
repeatedly with sterile saline and was sutured closed. All rats 
survived, and remained active following surgery.
Behavioral and electroencephalography (EEG) record‑
ings. Spontaneous behavioral seizures were observed in all 
animals, including controls, following the induction of SE and 
were usually detected for 60 days between 9 and 11 a.m., and 
between 3 and 5 p.m. each day using video monitoring. The 
recordings of the spontaneous seizures consisted of the latency 
period of SRS, seizure duration, frequency and intensity.
For the EEG recording, the rats were anesthetized using 
a mixture of 3% isoflurane in 30% oxygen and 70% nitrous 
oxide, and maintained with 1.5% isoflurane, and the animal 
was then fixed into the stereotaxic apparatus (RWd Life 
Science, Shenzhen, china). Electrodes were placed at the 
following positions on the skull using an electro-microdriver 
(RWd Life Science): 2.5 mm anterior to the bregma, 2.5 mm 
bilateral to the midline and 2.5 mm posterior to the lambda 
on the midline). The electrodes were then fixed with dental 
cement. Following recovery for 3 days, EEG monitoring was 
performed to evaluate the frequency and duration of EEG 
seizures. An EEG seizure was identified according to the 
definition of a period of consistent and repetitive changes 
in amplitude and frequency of electrical activity for at least 
10 sec, which was different from interictal activity (17). data 
were collected and analyzed using an acquisition system 
(Physical Signal Recorder RM6240; Chengdu Instrument 
Factory, chengdu, china).
Histological examination. The rats were deeply anesthe-
tized and then transcardially perfused with a successive 
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administration of 0.9% sterile saline and 4% paraformalde-
hyde (PFA) in 0.1 M PBS (pH 7.4; 4˚c). Following perfusion, 
the brains were removed from the skull and postfixed in 4% 
PFA for 24 h at 4˚c. Subsequently, the brains were rinsed in 
PBS and cryoprotected in 30% sucrose solution at 4˚c for 72 h. 
In particular, the coronal slices involving the middle region of 
the dorsal hippocampus were collected from between -3.6 and 
-4.0 mm to the bregma and sectioned into 25 µm-thick sections 
for staining using a freezing microtome (Leica cM 1850; 
Leica Microsystems GmbH, Wetzlar, Germany).
Immunohistochemical labeling was used to evaluate the 
protein distribution and expression. Based on standard proto-
cols, the sections were rinsed in PBS, and then incubated in 
0.1% hydrogen peroxide for 30 min to minimize endogenous 
peroxidase activity. The sections were then washed three times 
in PBS, placed in citrate buffer (pH 6.0) which had been heated 
to 90˚C, and then maintained for 20 min at room temperature to 
retrieve antigen. Following three washes with PBS, the sections 
were blocked with 10% normal goat serum (Sigma-Aldrich, 
Merck KGaA; darmstadt, Germany) and avidin (200 µl/ml; 
Avidin/Biotin blocking kit; Vector Laboratories, Burlingame, 
CA, USA) in PBS for 2 h at room temperature. Subsequently, 
the sections were incubated with primary rabbit ephrin-B3 
(1:50, sc-271328; Santa cruz Biotechnology, Inc., dallas, 
Texas, USA); mouse reelin (1:50, sc-25346; Santa cruz 
Biotechnology, Inc.); and rabbit p‑Dab1 (1:50, Tyr232; Affinity 
Biologicals, Inc., Ancaster, ON, canada) antibodies diluted in 
a solution containing 10% serum and avidin in PBS at 4˚C 
for 48 h. Following rinsing in PBS, the sections were incu-
bated in biotinylated anti-mouse or anti-rabbit or anti-goat 
secondary antiserum (1:200, 5260-0045, 5260-0038 and 
5260‑0035; KPL, Inc., Gaithersburg, MA, USA) for 1 h at 
room temperature. Following washing in PBS, the sections 
were incubated with the ABc reagent kit (VEcTASTAIN®, 
Vector Laboratories) for 2 h, visualized using dAB (Wuhan 
Boster Biological Technology, Ltd., Wuhan, china), and 
counterstained with hematoxylin. Images of the sections were 
captured using a Leica light microscope (Leica dM5000 B; 
Leica Microsystems GmbH) and analyzed using the ImagePro 
Plus 6.0 software package (Media Cybernetics, Inc., Rockville, 
Md, USA) by two investigators, in a blinded-manner, to calcu-
late the mean optical density of immunoreactive products in 
each microscopic view (magnification, x40).
Immunofluorescent labeling was performed based on stan-
dard protocols as described previously (2). The sections were 
incubated with primary antibodies, including goat doublecortin 
protein (dcX, 1:125; sc-8066; Santa cruz Biotechnology, Inc.) 
and rabbit neuronal nuclei (NeuN, 1:1,000; ab177487; Abcam, 
Cambridge, MA, USA) at 4˚C overnight and visualized with 
appropriate Alexa Fluor-conjugated secondary antibodies 
(1:1,000; A32723 and A32732; Invitrogen, Thermo Fisher 
Scientific, Inc., Waltham, MA, USA) at room temperature for 
6 h. All sections were counterstained with 4',6-diamidino-2-phe-
nylindole (DAPI; Wuhan Boster Biological Technology, Ltd.) 
and images were captured using a laser scanning confocal 
microscope (LSM 510; Leica Microsystems GmbH). For 
quantification analysis, five microscopic fields were selected 
to observe the distribution of newborn neurons and calculate 
the cell counts in each view (magnification, x40) using the 
ImagePro Plus 6.0 software package (Media Cybernetics, 
Inc.) by two investigators in a blinded manner. The positive 
cell counts were normalized to the total number of cells in the 
regions analyzed in the hippocampus.
SYBR Green‑based reverse transcription‑quantitative poly‑
merase chain reaction (RT‑qPCR) analysis. The rats were 
sacrificed 7, 14 and 60 days following the termination of SE, 
and the hippocampus was rapidly dissected and transferred 
to liquid nitrogen. All the hippocampal samples were stored 
at -80˚c until processing. Total RNA was extracted using 
TRIzol reagent (Invitrogen; Thermo Fisher Scientific, Inc.), 
and reverse transcribed into cdNA using a RevertAid™ 
First-Strand complementary dNA (cdNA) synthesis kit 
(Thermo Fisher Scientific, Inc.). The qPCR sample contained 
the following: 1 µl cdNA, 1 µl sense primer, 1 µl antisense 
primer, 9.5 µl RNase-free water and 12.5 µl Maxima® SYBR-
Green/ROX qPCR Master mix (Thermo Fisher Scientific, 
Inc.) to obtain a 25 µl reaction volume. The sequences of PCR 
primers and PCR product lengths were as follows: Ephrin‑B3 
(NM_001406), forward 5'-AcT cAG ccT GGA Gcc TGT cTA 
c-3' and reverse 5'-cGA TcT GAG GGT AAA GcA cGT A-3' 
(212 bp); and β-actin (NM_007993.3), forward 5'-AAT AAG 
TGG TTA cAG GAA G-3' and reverse 5'-GTA TTA AGG cGG 
AAG ATT-3' (164 bp). The reactions were performed using 
the following cycling conditions: Enzyme activation at 95˚c 
for 10 min, followed by 40 cycles of denaturation at 95˚c for 
15 sec, annealing at 60˚c for 1 min and extension at 72˚c for 
20 sec. The relative expression levels were calculated as ratios 
normalized against those of β-actin and assessed using the 
ABI StepOnePlus™ real‑time PCR system (Thermo Fisher 
Scientific, Inc.). The qPCR data were analyzed using the 2-∆∆cq 
method as described previously (18).
Western blot analysis. The stored hippocampal samples from 
the rats sacrificed 7, 14 and 60 days following the termination 
of SE were homogenized in 400 µl RIPA lysis buffer (Beyotime 
Institute of Biotechnology, Shanghai, china) supplemented 
with the protease inhibitor PMSF (Beijing Solarbio Science 
& Technology co., Ltd., Beijing, china) and the phosphatase 
inhibitor PhosSTOP (Roche Diagnostics, Basel, Switzerland). 
The lysates were centrifuged at 14,000 x g for 20 min at 4˚C. 
Bicinchoninic acid assays were used to determine protein 
concentrations, as described previously (19). Equal quantities 
of protein (50 µg) extracts were separated by electrophoresis 
on 12% polyacrylamide gels at 120 V. The proteins were then 
transferred onto polyvinylidence difluoride membranes in 
120 mM glycine, 125 mM Tris, 0.1% sodium dodecyl sulfate 
and 20% methanol at 150 mA for 1.5 h. The membranes 
were blocked in 5% non-fat dry milk in Tris-buffered saline 
containing 0.1%Tween-20 (TBST) at 4˚c. The membranes 
were then incubated with the following primary antibodies: 
Anti-ephrin-B3 (1:1,000; sc-271328; Santa cruz Biotechnology, 
Inc.); anti-p-dab1 antibodies (1:1,000; Tyr232; Affinity 
Biologicals); anti-dab1 (1:2,000; sc-271136; Santa cruz 
Biotechnology, Inc.) overnight at 4˚c. Secondary antibodies 
(1:2,000; 5220‑0283, 5220‑0460 and 5450‑0010; KPL, Inc.) 
conjugated to horseradish peroxidase were used at a dilution 
of 1:1,000 in blocking solution at room temperature for 2 h. 
The membranes were then washed three times with TBST and 
labeling was visualized using enhanced chemiluminescence 
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reagent (Thermo Fisher Scientific, Inc.). The specific bands 
visible on images were scanned using the Bio-Rad Gel 
doc 2000 imaging system (Bio-Rad Laboratories, Inc., 
Hercules, cA, USA) and measured with Image Lab 3.0 image 
analysis software (Bio-Rad Laboratories, Inc.). The relative 
intensities of ephrin-B3 were normalized to the internal refer-
ence protein β‑actin (1:1,000; ABP50151; Beyotime Institute 
of Biotechnology) and the relative intensity of p-dab1 was 
normalized to total dab1.
Statistical analysis. All results are presented as the 
mean ± standard deviation. Statistical analyses were performed 
using GraphPad Prism 6.0 (GraphPad Software, Inc., La Jolla, 
CA, USA). All continuous variables were tested to confirm that 
they fit a normal distribution or homoscedasticity according 
to the results of Levene's test prior to further analysis. 
comparisons among groups were analyzed using two-way 
analysis of variance (ANOVA), followed by multiple Tukey's 
post hoc test (α=0.05) to assess the difference between any 
two groups. EEG data between groups was compared using 
one-way ANOVA, followed by Tukey's post hoc test. P<0.05 
was considered to indicate a statistically significant difference.
Results
Dynamic expression pattern of ephrin‑B3 in rats during the 
development of SE. The results of the RT‑qPCR analysis 
showed a significant downregulation in the gene expression 
of ephrin-B3 in the hippocampal tissues of epileptic rats 
(Ep group) during the three phases of SE development (P<0.05; 
Fig. 1A). Following pilocarpine-induced SE, the expression of 
ephrin-B3 was lower in the 7 days group compared with that 
in the 60 days group, and the lowest expression was observed 
in the 14 days group (P<0.05).
Subsequently, immunohistochemistry was used to clarify 
the distribution of ephrin-B3 in the rat hippocampus; repre-
sentative images are shown in Fig. 1B. The results of the 
immunohistochemistry revealed that eprhin-B3 was promi-
nent in granule cells in the dentate gyrus, subgranular zone 
and hilus in the hippocampus, was sparse in the inner and 
outer molecular layers, and was mainly expressed in the cell 
membrane. Additionally, the expression of ephrin-B3 in the 
hippocampus was decreased in the 14 days group, compared 
with that in the 7 days group, but was increased in the 60 days 
group (Fig. 1C). These results were confirmed by detecting 
the protein expression of ephrin-B3 by western blot analysis, 
which showed similar dynamic changes to gene expres-
sion (Fig. 1d and E).
Hippocampal neurogenesis in rats during the development 
of SE. To examine hippocampal neurogenesis following 
pilocarpine-induced SE, dcX and NeuN were used for 
double-labeling to measure the changes in newborn neurons 
in the hippocampus post-SE, as they can recognize late 
mitotic neuronal precursors and newly-generated postmitotic 
neurons. dcX is a marker of transit-amplifying cells and 
immature neurons, which begin to have neuronal potential, 
whereas NeuN labels postmitotic neurons, which have been 
found to be mature granule cells. The dcX/NeuN-positive 
cells showed the features of newly generated neurons in 
the rats; representative images are shown in Fig. 2A. The 
number of newborn neurons was significantly increased in 
the rats following pilocarpine‑induced SE (P<0.05; Fig. 2B). 
consistent with the increased number of newborn neurons, the 
dcX-positive cells in the Ep rats clustered along the subgran-
ular zone and revealed premature branching of the dendritic 
outgrowth within the granule cell layer, random and nonradial 
orientation of the outgrowth, and numerous abnormal neuronal 
processes when compared with the control group. The images 
indicated the abnormal positioning of dcX-positive cells 
in the hippocampus and abnormal morphology of dendritic 
outgrowth following pilocarpine induction.
Reelin pathway expression in rats during the development of 
SE. As shown in Fig. 3A, the immunohistochemistry results 
revealed a significant downregulation in the expression of reelin 
in the rat hippocampus during the three phases of SE, with a 
lower expression at 7 days, compared with that at 60 days, and 
the lowest expression observed at 14 days (P<0.05; Fig. 3B). The 
immunohistochemistry also revealed the distribution of reelin, 
which was mainly expressed in the interneurons in the dentate 
gyrus, hilus and subgranular zone, and labeled as numerous 
punctate structures on the cell membrane. The phosphoryla-
tion of dab1 is necessary for the activation of reelin signaling. 
The immunohistochemistry revealed that, compared with the 
control rats, the Ep rats showed significantly decreased expres-
sion of p‑Dab1 on days 7, 14 and 60 post‑SE induction (P<0.05; 
Fig. 3c and d). The immunohistochemistry also revealed that 
p-dab1 was labeled in the dentate granule cell body in the 
hilus and dentate gyrus, the inner molecular layer and stratum 
radiatum of the hippocampus. In addition, the expression levels 
of p-dab1 and total dab1 were assessed using western blot 
analysis following pilocarpine-induced SE (Fig. 3E and F). 
The expression of p-dab1 was downregulated, whereas that of 
total dab1 remained unchanged.
Effects of ephrin‑B3 stimulator on hippocampal neurogenesis. 
To further examine whether ephrin-B3 can affect hippocampal 
neurogenesis in the hippocampus in Ep rats, a stimulator of 
ephrin-B3 with EphB3-Fc/Fc-control was injected into the Ep 
rats 7 days following pilocarpine-induced SE (Fig. 4A). The 
expression level of ephrin‑B3 was confirmed to be upregu-
lated following injection with EphB3-Fc, whereas no changes 
were found in the Fc-control groups (Fig. 4B). As shown 
in Fig. 4c and d, following EpB3-Fc injection, the number of 
newborn neurons was significantly decreased, compared with 
that following Fc‑control treatment (P<0.05). DCX‑labeled 
cells in the Ep rats post-EphB3-Fc treatment were scattered 
in the subgranular zone, with short dendrites that extended 
through <1/3 of the granular cell layer, compared with those in 
the Fc‑control group. No significant difference was observed 
in the control groups between the EphB3-Fc and Fc-control 
treatments. These results suggested that EphB3-Fc reduced the 
number of newborn neurons and abnormal dendritic outgrowth 
following pilocarpine-induced SE.
Effects of ephrin‑B3 stimulator on the reelin pathway. To 
further examine whether ephrin-B3 can affect the protein 
expression levels of reelin and p-dab1 in the hippocampus of 
Ep rats, the present study detected the expression levels of reelin 
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and p-dab1 following EphB3-Fc injection (Fig. 5). The immu-
nohistochemistry results showed that the injection of ephrin-B3 
stimulator markedly increased the expression levels of reelin 
in the hippocampus of Ep rats post‑SE (P<0.05), whereas 
no significant increase in the protein expression of reelin 
was observed in the rats injected with Fc-control (Fig. 5A). 
In addition, as shown in Fig. 5B and c, the expression of 
p-dab1 detected by immunohistochemistry was increased 
Figure 1. dynamic expression patterns of ephrin-B3 in the hippocampus of rats during the development of SE. (A) mRNA expression of ephrin-B3 in each 
group, as assessed by reverse transcription‑quantitative polymerase chain reaction analysis. The results showed significant downregulation in the gene expres-
sion of ephrin-B3 in the rat hippocampal tissues during the three phases of SE development. (B) Representative immunohistochemical staining of protein 
expression and distribution of ephrin-B3 in the hippocampus. (c) Results of the mean optical density of ephrin-B3 in the hippocampus. (d) Western blot 
analysis for the expression of ephrin-B3. (E) Quantitative results of protein expression of ephrin-B3 detected by western blot analysis indicated that Ep reduced 
the protein expression of Ephrin-B3. data are presented as the mean ± standard deviation. Scale bar=100 µm. ***P<0.0001, *P<0.01 by two‑way analysis of 
variance with Tukey's post hoc test (n=6 rats/per group); Ep, epilepsy; con, control.
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Figure 3. Reelin pathway expression in the hippocampus of rats during the development of SE. (A) Representative immunohistochemical staining of reelin 
protein in hippocampal tissues during the three phases of SE development. Left: representative immunohistochemical staining of reelin protein (Scale 
bar=50 µm); right: High‑magnification bright‑field images and arrows indicating the immunopositive cells (Scale bar=10 µm). (B) Bar graph results of 
reelin protein in hippocampal tissues during the three phases of SE development. (c) Representative immunohistochemical staining of p-dab1 protein in the 
hippocampus. Left: representative immunohistochemical staining of p‑Dab1 protein (Scale bar=50 µm); right: high‑magnification bright‑field images and the 
arrows indicate the immunopositive cells (Scale bar=10 µm). (d) Bar graph results of p-dab1 protein in the hippocampus. (E) Western blot analysis for p-dab1. 
β‑actin was used as an endogenous control. (F) Quantification of western blot results of p‑Dab1, presented as the p‑Dab1/Dab1 ratio. Data are presented as the 
mean ± standard deviation. ***P<0.0001, **P<0.001 by two‑way analysis of variance with Tukey's post hoc test (n=3 rats/per group). Ep, epilepsy; Con, control; 
dab1, disabled 1; p-dab, phosphorylated dab1.
Figure 2. Hippocampal neurogenesis in rats during the development of SE. (A) Representative immunofluorescent results of hippocampal neurogenesis using 
DCX (green), NeuN (red) and DAPI (blue) antibodies to identify progenitor cells (green) and mature neurons (red). The arrows indicate the DCX/DAPI 
co‑labeled newborn neurons. High‑magnification bright‑field images are shown in the boxed section. (B) Quantification results of DCX‑positive cells in the 
hippocampus. Ep rats showed more mislocalized progenitors in the hippocampus, compared with the control rats. data are presented as the mean ± standard 
deviation. Scale bar=50 µm. ***P<0.0001 by two‑way analysis of variance with Tukey's post hoc test (n=5 slices/per group). Ep, epilepsy; DCX, doublecortin; 
DAPI, 4',6‑diamidino‑2‑phenylindole.
INTERNATIONAL JOURNAL OF MOLEcULAR MEdIcINE  41:  3457-3467,  2018 3463
following EphB3‑Fc treatment (P<0.05), whereas Fc‑control 
treatment had no effect on the level of p-dab1 post-SE. The 
expression of p‑Dab1 was also confirmed using western blot 
analysis (Fig. 5d and E), which also showed upregulation in 
the hippocampus of Ep rats following EphB3-Fc treatment. By 
contrast, the hippocampal level of total dab1 was not altered 
following EphB3‑Fc or Fc‑control treatment. No significant 
difference was found in the expression of reelin or p-dab1 
in the control rats between the EphB3-Fc and Fc-control 
treatment groups.
Characteristics of behaviors and EEG following ephrin‑B3 
stimulation treatment in the rat model. All the rats were 
monitored to record their behaviors and EEG. The control 
animals without injections of pilocarpine did not exhibit 
seizure activities. Following several minutes of pilocarpine 
injection, the rats exhibited facial muscle, forelimb and tail 
clonus, and ataxic lurching, head bobbing and wet dog shakes. 
In the latent stage of SE (14 days post-SE), no behavioral 
changes or seizures were observed in the Ep rats. Spontaneous 
recurrent seizures occurred at 60 days post-SE in the Ep rats 
(chronic stage of SE). However, following EphB3-Fc treat-
ment, it was found that the Ep rats exhibited reduced average 
latency periods to the onset of seizure, seizure thresholds and 
seizure frequencies, compared with the Fc-control-treated 
rats (P<0.05); whereas Fc‑control treatment had no effect 
on seizures. No significant difference was found in seizure 
activities of the control rats following EphB3-Fc or Fc-control 
treatment (data not shown).
EEG recordings that showed high frequency and amplitude, 
poly-spike paroxysmal electrical activities, and persisted for at 
least 10 sec were considered to be EEG seizures (Fig. 6A-c). 
No EEG changes or seizures were observed in the control 
rats. The pilocarpine-induced rats exhibited EEG seizures 
characterized by a recruiting rhythmic activity followed by 
spiking activity of progressively increased frequency and 
voltage. Treatment with EphB3‑Fc significantly suppressed the 
frequency, duration and the firing amplitudes of spontaneous 
seizures in the Ep rats. However, no significant differences 
were found in frequency, duration or epileptiform activity in 
the control rats following EphB3-Fc or Fc-control treatment.
Discussion
The present study is the first, to the best of our knowledge, 
to demonstrate the role of ephrin-B3 in neurogenesis 
and the reelin pathway during the development of SE in 
epileptic rats. By integrating the data, it was found that the 
expression of ephrin‑B3 was significantly downregulated in 
epileptic rats; the expression of ephrin-B3 was lower in the 
acute phase, compared with that in the chronic phase, and 
was lowest in the latent phase. The reelin pathway showed 
similar dynamic changes to the expression of ephrin-B3. The 
pilocarpine-induced rats exhibited increased hippocampal 
neurogenesis during the spontaneous period of SE. The 
effects of ephrin-B3 on hippocampal neurogenesis and reelin 
pathway expression levels were examined, and it was found 
that, following the administration of exogenous ephrin-B3, the 
Figure 4. Effect of EphB3-Fc on hippocampal neurogenesis post-SE. (A) Schematic of a typical coronal hippocampal section, illustrating the region of 
EphB3-Fc injection. Asterisks represent the injection sites. (B) Expression of ephrin-B3 increased following EphB3-Fc infusion, detected by western blot 
analysis. (C) Representative immunofluorescent results of hippocampal neurogenesis using DCX (green), NeuN (red) and DAPI (blue) antibodies to identify 
progenitor cells (green) and mature neurons (red). The arrows indicate the DCX/DAPI co‑labeled newborn neurons. High‑magnification bright‑field images 
are shown in the boxed section. (D) Bar graph results of the immunofluorescent results. Following EphB3‑Fc treatment, Ep rats showed fewer DCX‑labeled 
cells, compared with the Fc‑control rats, whereas no significant difference was found between EphB3‑Fc and Fc‑control treatment in the control rats. Data 
are presented as the mean ± standard deviation. Scale bar=50 µm. ***P<0.0001, ns, (P>0.05) by two‑way analysis of variance with Tukey's post hoc test 
(n=5 slices/per group). Ep, epilepsy; DCX, doublecortin; DAPI, 4',6‑diamidino‑2‑phenylindole; ns, not significant.
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epileptic rats showed subsequent increases in hippocampal 
reelin pathway expression and reduced neurogenesis, accom-
panied by the suppression of spontaneous seizures. These 
results suggested the underlying functions of ephrin-B3 on 
the modulation of the reelin pathway, and the suppression of 
neurogenesis and seizure activity in epilepsy.
Increasing investigations have started to investigate the 
role of Eph receptor and its ligand ephrins in the central 
nervous system (20). Ephrin-B3, the ligand of EphB receptor 
is critical in the regulation of cell signaling, neuronal migra-
tion and cell proliferation, dendritic spine maturity, formation 
of excitatory synapses, and synaptic plasticity in the central 
nervous system (21,22). In a previous animal study, mice 
lacking ephrin-B3 or EphB1 receptor exhibited disrupted 
hippocampal neurogenesis, including polarity, cell positioning 
and proliferation (8). In the present study, it was demonstrated 
that ephrin‑B3 was significantly decreased post‑SE in epileptic 
rats, which corroborated with the previous finding that the 
involvement of ephrin-B3 is an important regulator of neuronal 
cell positioning in the central nervous system (12). The present 
study also found that the expression of ephrin-B3 was margin-
ally increased in epileptic rats in the chronic phase. A possible 
Figure 5. Effect of EphB3-Fc on reelin pathway expression in the hippocampus post-SE. (A) Representative immunohistochemical staining of reelin following 
EphB3‑Fc/Fc‑control treatment. Left: representative immunohistochemical staining of reelin (scale bar=50 µm); right: high‑magnification bright‑field 
images and the arrows indicate the immunopositive cells (scale bar=10 µm). (B) Bar graph results of the immunohistochemistry assay of reelin protein. 
(c) Representative immunohistochemical staining of p-dab1 following EphB3-Fc/Fc-control treatment. Left: representative immunohistochemical staining 
of p‑Dab1 (scale bar=50 µm); right: high‑magnification bright‑field images and the arrows indicate the immunopositive cells (scale bar=10 µm). (D) Bar 
graph results of the immunohistochemistry assay of p-dab1. (E) Western blot analysis for expression of p-dab1. β-actin was used as an endogenous control. 
(F) Quantification of p‑Dab1 expression by western blot analysis. Data are presented as the mean ± standard deviation. ***P<0.0001, **P<0.001, *P<0.01, 
ns= P>0.05 by two‑way analysis of variance with Tukey's post hoc test (n=3 rats/per group). Ep, epilepsy; Con, control; Dab1, disabled 1; p‑Dab, phosphorylated 
Dab1; ns, not significant.
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explanation for this increase is that ephrin-B3 binding to its 
cognate receptor can induce a small depression of excitatory 
synaptic transmission in cultured hippocampal neurons (23). 
The increase of ephrin-B3 may serve as a compensatory 
mechanism to maintain homeostatic balance in the chronic 
stage of SE.
Hippocampal neurogenesis in several animal models of 
epilepsy can result in alteration of the excitability of neurons, 
which contributes to spontaneous recurrent seizures (24,25). 
Seizures can activate progenitor cells in the subgranular 
zone of the dentate gyrus in the hippocampus, and these 
newborn neurons integrate into the hippocampal circuitry 
and contribute to hippocampal network plasticity, thereby 
affecting epilepsy (25,26). consistent with the findings 
in the present study, Song et al also found that newborn 
neurons exhibited abnormal dendritic development, including 
longer apical and basal dendrites, and were accompanied by 
long-term seizure activity in an intraventricular kainic acid 
model of epilepsy (27). Of note, the hippocampal neurogenesis 
and neuronal migration stimulated by SE were prominent 
at least within 28 days, which coincided with the finding in 
the latent phase in the present study (24). By comparing the 
number and features of newborn neurons following EphB3-Fc 
injection, the epileptic rats showed a reduction in proliferation, 
altered migration and relatively normal branching of newborn 
neurons. These results further support the hypothesis that 
ephrin-B3 is involved in regulating the proliferation and 
migration of neural progenitors during the development of SE.
Furthermore, the present study examined the role of 
ephrin-B3 in the regulation of reelin pathway during the 
Figure 6. EEG recordings. (A) EEG activity of control rats and epileptic rats. Ep rats showed typical EEG seizures (a1). (B) Spontaneous EEG seizures in Ep 
rats following EphB3‑Fc/Fc‑control treatment. Compared with the Fc‑control treated rats, treatment with EphB3‑Fc significantly suppressed the frequency of 
spontaneous seizures, as demonstrated by reduced epileptiform activity in the Ep rats (b1 vs. b2). Each box indicated the enlargement of the corresponding EEG 
sample. (C) Quantification of the frequency of EEG seizures, seizure amplitude and mean duration of EEG seizures. Data are presented as the mean ± standard 
deviation. ***P<0.0001, ns=P>0.05 by two‑way analysis of variance with Tukey's post hoc test (n=3 rats/per group). Ep, epilepsy; EEG, electroencephalography.
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development of SE. In association with other observations 
in human temporal lobe epilepsy specimens (28), the present 
study showed the downregulation of reelin pathway expression 
in epileptic rats, which indicated that this pathway may also 
be involved in neuronal migration post-SE. Several studies 
have suggested that reelin is also associated with epilepsy; for 
example, reelin deficiency has an effect on granule cell disper-
sion in mesial temporal lobe epilepsy (29), and heterozygous 
reelin mutation is associated with a clinical phenotype of 
temporal lobe epilepsy in humans (30). Baek et al also found 
that the misexpression of reelin can lead to a migration defect 
in neurons of focal malformations in cortical development 
in the human and mouse brain (31). In addition, a previous 
study demonstrated that Dab1‑deficient mice exhibit inter-
ictal epileptiform abnormalities and a reduced latency to 
pilocarpine‑induced SE (32), which is similar to the findings 
in the present study. However, following the administration 
of exogenous ephrin-B3 with EphB3-Fc in the present study, 
subsequent upregulation in the expression of reelin and down-
stream p‑Dab1 were observed in the hippocampus. This finding 
is consistent with a report by Senturk et al, which showed the 
ephrin-B3 can activate the reelin pathway in reelin-knockout 
mice (12). However, the findings in the present study are the 
first, to the best of our knowledge, to demonstrate the dynamic 
changes in the reelin pathway and the role of ephrin-B3 in 
modulating the reelin pathway during the development of SE.
There were limitations to the present study. First, only one 
time point was examined, rather than longitudinal behavioral 
and molecular changes following injection. This is due to our 
findings that ephrin‑B3 and reelin decreased from 7 days and 
were expressed at its lowest level in 14 days. Secondly, the 
present study only showed the expression of the reelin pathway 
following exogenous ephrin-B3 injection, with no intervening 
of the reelin pathway; future investigations aim to include 
interventional methods to further investigate the downstream 
proteins and confirm the effect of ephrin‑B3 on the reelin 
pathway. Finally, preclustered Eph-B3-Fc molecules increase 
ephrin-B3 protein by its bidirectional signaling (33), therefore, 
it is possible to cluster ephrin-B1 or B2 (7). However, ephrin-B3 
is the primarily activated protein by EphB3-Fc in cortical 
and hippocampal neurons according to previous studies (12). 
Therefore, may be useful to examine the function of ephrin-B1 
or B2 and attempt other genetic methods, including ephrin-B3 
transgenic mice, in the future.
In conclusion, the observations in the present study 
provide evidence that ephrin-B3 is key in the amelioration 
of neurogenesis and suppression of neuronal excitation in 
epilepsy. Furthermore, ephrin-B3 was found to be involved in 
modulation of the reelin signaling pathway during the devel-
opment of epilepsy. These findings support the hypothesis 
that the administration of ephrin-B3 may assist in preventing 
recurrent seizures, at least in an animal model. Further inves-
tigations are required to validate whether, and to what extent, 
the results obtained in the present study can be extrapolated 
to patients.
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